Showing results (51-60 of 71) with videos related to
Sort By:
Pageof 8
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 14, 2021
Facilitated cascade testing (FaCT): a randomized controlled trialRoni Nitecki, Haley A Moss, Catherine H Watson, et al.American Journal of Obstetrics and Gynecology|February 18, 2026
Survival Outcomes After Inadvertent Surgery in Low-Risk Early-Stage Cervical CancerNuria Agustí, David Viveros-Carreño, Chi-Fang Wu, et al.Familial Cancer|May 15, 2024
Cascade genetic testing: an underutilized pathway to equitable cancer care?Roni Nitecki Wilke, Erica M Bednar, Sara Pirzadeh-Miller, et al.Obstetrics and Gynecology|November 11, 2022
Obstetric and Neonatal Outcomes 1 or More Years After a Diagnosis of Breast CancerKirsten Jorgensen, Roni Nitecki, Hazel B Nichols, et al.Cancer|June 29, 2022
Survival outcomes following pregnancy or assisted reproductive technologies after breast cancer: A population-based studyJ Alejandro Rauh-Hain, Jose Zubizarreta, Roni Nitecki, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 17, 2021
Employment disruption among women with gynecologic cancersRoni Nitecki, Shuangshuang Fu, Kirsten A Jorgensen, et al.American Journal of Obstetrics and Gynecology|November 3, 2025
Salpingectomy in individuals at high risk for tubo-ovarian cancer: consensus and precautionRoni Nitecki Wilke, Kathryn P Pennington, Tamar A Gootzen, et al.JAMA Network Open|July 25, 2025
Neoadjuvant Chemotherapy, Case Volume, and Mortality in Advanced Ovarian CancerMary Kathryn Abel, Varvara Mazina, Amy J Bregar, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 8, 2026
Oral cyclophosphamide combined with bevacizumab in recurrent heavily pre-treated ovarian cancerMostafa F Eyada, Victoria Michael, Shrina Patel, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 9, 2026
Frequency of lymph node involvement in clinically early-stage low-grade serous ovarian cancer: a systematic review and meta-analysisDavid Viveros-Carreño, Nuria Agustí, Nathalia Mora-Soto, et al.Pageof 8